During last 10 years the number of studies which devoted to using of medical physical factors in rehabilitation of patients with breast cancer has increased. Using any physical factor in rehabilitation should be proved by results of evidence-based studies.The article presents data of scientometric analysis of 748 studies from 1980 till 2018 which were devoted to using of medical physical factors in rehabilitation of 261643 patients with breast cancer. The most studied physical factors with authentically proven effect are physical exercises, water based physical exercises, compression therapy. Process of synthesis and analysis of study results should be done regularly.

Taking into account the multifunctional disorders and consequences of oncological diseases and their treatment, rehabilitation in oncology has many goals and is aimed at restoring the physical, emotional, social, role and cognitive functioning of the patient, as well as returning the patient to previous labor activity. The principles of rehabilitation measures vary considerably from country to country, depending on the social security system in which they are included. In most European countries and in theUnited States of America, rehabilitation activities are mainly carried out on an outpatient basis. Whereas inGermanythere is a unique system in which rehabilitation is performed mainly in a hospital environment. This article presents an overview of rehabilitation measures in oncology practice conducted in different countries.

Russia; 68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia; 2 "Onco-system" Ltd; 11/1 Hoshimina St., Saint Petersburg 194356, Russia; 3 Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of Russia; 70 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia Head and neck tumors (HNT)

No abstract

Петербургский клинический научно-практический центр специализированных видов медицинской помощи (онкологический)», Санкт-Петербург, Россия РЕЗЮМЕ В обзоре представлены данные о классификации, механизмах развития и клинических проявлениях нейротоксичности. Проанализированы основные особенности нейротоксичности при использовании таксанов, включая кумулятивные дозы. Рассмотрены доказанные методы лечения и профилактики нейропатии, вызванной цитостатическими препаратами.